Conference Reports for NATAP
HIV R4P
Jan & 27 - 28
Feb 3 & 4 - 2021
Back
 
Tweet
Long acting injectable cabotegravir is safe and
effective in preventing HIV infection in cisgender women: results from HPTN 084